ASCO 2018: Dendritic Cell Vaccine Has Been Proven to Be a Promising Maintenance Treatment Option to Delay Progression of Epithelial Ovarian Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.